These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 10695681)

  • 1. Synthesis and biological properties of a novel cephalosporin FR86521 having potent activity against methicillin-resistant Staphylococcus aureus (MRSA).
    Kishi K; Ohki H; Okuda S; Kawabata K; Sakane K; Matsumoto Y; Matsumoto S; Tawara S
    J Antibiot (Tokyo); 1999 Dec; 52(12):1152-5. PubMed ID: 10695681
    [No Abstract]   [Full Text] [Related]  

  • 2. New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Part 2: Synthesis and structure-activity relationships in the S-3578 series.
    Yoshizawa H; Kubota T; Itani H; Ishitobi H; Miwa H; Nishitani Y
    Bioorg Med Chem; 2004 Aug; 12(15):4211-9. PubMed ID: 15246097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S-3578, a new broad spectrum parenteral cephalosporin exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Synthesis and structure-activity relationships.
    Yoshizawa H; Itani H; Ishikura K; Irie T; Yokoo K; Kubota T; Minami K; Iwaki T; Miwa H; Nishitani Y
    J Antibiot (Tokyo); 2002 Nov; 55(11):975-92. PubMed ID: 12546419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel cephalosporins 1. Synthesis of 3-benzothiopyranylthiovinyl cephalosporins and antibacterial activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis.
    Yamazaki H; Tsuchida Y; Satoh H; Kawashima S; Hanaki H; Hiramatsu K
    J Antibiot (Tokyo); 2000 May; 53(5):546-50. PubMed ID: 10908120
    [No Abstract]   [Full Text] [Related]  

  • 5. New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Part 3: 7beta-[2-(5-Amino-1,2,4-thiadiazol-3-yl)-2-ethoxyiminoacetamido] cephalosporins bearing 4-[3-(aminoalkyl)-ureido]-1-pyridinium at C-3'.
    Yoshizawa H; Kubota T; Itani H; Minami K; Miwa H; Nishitani Y
    Bioorg Med Chem; 2004 Aug; 12(15):4221-31. PubMed ID: 15246098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel cephalosporins 2. Synthesis of 3-heterocyclic-fused thiopyranylthiovinyl cephalosporins and antibacterial activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis.
    Yamazaki H; Tsuchida Y; Satoh H; Kawashima S; Hanaki H; Hiramatsu K
    J Antibiot (Tokyo); 2000 May; 53(5):551-5. PubMed ID: 10908121
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-MRSA cephems. Part 1: C-3 substituted thiopyridinium derivatives.
    Springer DM; Luh BY; Bronson JJ
    Bioorg Med Chem Lett; 2001 Mar; 11(6):797-801. PubMed ID: 11277523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antibacterial activity of TOC-50, a new parenteral cephalosporin against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
    Nomura S; Hanaki H; Unemi N
    Chemotherapy; 1996; 42(4):253-8. PubMed ID: 8804792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CP6679, a new injectable cephalosporin with broad spectrum and potent activities against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa.
    Ida T; Tsushima M; Ishii T; Atsumi K; Tamura A
    J Infect Chemother; 2002 Jun; 8(2):138-44. PubMed ID: 12111566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activities of a novel cephalosporin, CB-181963 (CAB-175), against methicillin-susceptible or -resistant Staphylococcus aureus and glycopeptide-intermediate susceptible staphylococci.
    Huang V; Brown WJ; Rybak MJ
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2719-23. PubMed ID: 15215134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on anti-MRSA parenteral cephalosporins. III. Synthesis and antibacterial activity of 7beta-[2-(5-amino-1,2,4-thiadiazol-3-yl)-2(Z)-alkoxyiminoacetamido-3.
    Ishikawa T; Kamiyama K; Nakayama Y; Iizawa Y; Okonogi K; Miyake A
    J Antibiot (Tokyo); 2001 Mar; 54(3):257-77. PubMed ID: 11372783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationships of cephalosporin derivatives against methicillin-resistant Staphylococcus aureus and Enterococcus faecalis.
    Hanaki H; Akagi H; Nomura S; Unemi N; Hiramatsu K
    J Antibiot (Tokyo); 1996 Apr; 49(4):402-4. PubMed ID: 8642007
    [No Abstract]   [Full Text] [Related]  

  • 13. New anti-MRSA cephalosporins with a basic aminopyridine at the C-7 position.
    Cho A; Glinka TW; Ludwikow M; Fan AT; Wang M; Hecker SJ
    Bioorg Med Chem Lett; 2001 Jan; 11(2):137-40. PubMed ID: 11206444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and structure-activity relationship of a series of 1-carba-1-dethiacephems exhibiting activity against methicillin-resistant Staphylococcus aureus.
    Ternansky RJ; Draheim SE; Pike AJ; Bell FW; West SJ; Jordan CL; Wu CY; Preston DA; Albron W; Kasher JS
    J Med Chem; 1993 Jul; 36(14):1971-6. PubMed ID: 8336336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antistaphylococcal activity of the novel cephalosporin CB-181963 (CAB-175).
    Miller K; Storey C; Stubbings WJ; Hoyle AM; Hobbs JK; Chopra I
    J Antimicrob Chemother; 2005 Apr; 55(4):579-82. PubMed ID: 15722396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The in-vitro antibacterial activity of a combination of cefpirome or cefoperazone with vancomycin against enterococci and Staphylococcus aureus.
    Seibert G; Isert D; Klesel N; Limbert M; Markus A; Schrinner E
    J Antimicrob Chemother; 1992 Apr; 29 Suppl A():25-30. PubMed ID: 1601753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity profile of ceftobiprole, an anti-MRSA cephalosporin, against recent gram-positive and gram-negative isolates of European origin.
    Pillar CM; Aranza MK; Shah D; Sahm DF
    J Antimicrob Chemother; 2008 Mar; 61(3):595-602. PubMed ID: 18218646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on anti-MRSA parenteral cephalosporins. I. Synthesis and antibacterial activity of 7beta-[2-(5-amino-1,2,4-thiadiazol-3-yl)-2(Z)- hydroxyiminoacetamido]-3-(substituted imidaz.
    Ishikawa T; Iizawa Y; Okonogi K; Miyake A
    J Antibiot (Tokyo); 2000 Oct; 53(10):1053-70. PubMed ID: 11132950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial activities of Ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureus.
    Sader HS; Fritsche TR; Jones RN
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1153-5. PubMed ID: 18180353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus.
    Jones ME
    Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():17-24. PubMed ID: 17488372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.